CClinicalTrials.gg
WithdrawnNCT05570682HASTEUpdated Mar 28, 2025

Manually Controlled Infusion Vs Target Controlled Infusion for StrokeThrombectomy

An interventional study of TCI and Manual induction in Stroke, Ischemic, Stroke/Brain Attack and Anesthesia, sponsored by University of Padova. Withdrawn at 1 site in Italy. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-03-28.

Sponsored by University of Padova · Not applicable, Interventional, and Treatment

Why this study was withdrawn
No particpants was enrolled as after IRB cleareance there was no more logistical feasibiliy to enroll patients.
Phase
Not applicable
Study type
Interventional
Enrollment
0
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The goal of this randomized controlled trial is to compare manual general anesthesia induction to general anesthesia induction guided by target controlled infusion system in cerebral ischemic stroke

The main questions it aims to answer are:

  • Does target controlled infusion has a more favorauble hemodynamic profile than manual general anesthesia induction?
  • Do patients receiving general anesthesia with target controlled infusion system have a more favourable outcome? Participants will receive general anesthesia induction with a target controlled infusion system and will be compared to patients receiving manual general anesthesia induction.
02

Conditions studied

  • Stroke, Ischemic
  • Stroke/Brain Attack
  • Anesthesia
  • Hemodynamic Instability
03

In context

Stroke

7,286 studies on the registry are indexed under Stroke; 2,007 are open to participants now.

Browse Stroke studies →

Lead sponsor

University of Padova is the lead sponsor of 210 studies on the registry; 42 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Age ≥ 18 years;
  • Anterior Cerebral Circulation Stroke
  • Patient eligible for mechanical trombectomy
  • mRS ≤ 2;
  • Fasting patients (>6 h solid, >2 hours liquids)
  • Glashow Coma Scale more than seven.

Exclusion criteria

Exclusion criteria

  • Patient in general anesthesia at hospital arrival
  • Associated hemorrhagic stroke
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
0 participants (actual)

Study arms

  • Active comparator
    Manual induction

    General Anesthesia induction: Fentanyl 2 mcg/kg, Propofol 2 mg/kg, Rocuronium 0.6 mg/kg General Anesthesia mainteneance: Propofol 4-6 mg/kg/h to keep an adequate sedation level (BIS between 40-60; entropy between 40-60)

    Procedure: Manual induction

  • Experimental
    Target Controlled Induction

    General Anesthesia induction: Fentanyl 2 mcg/kg, Propofol TCI with Schneider site effect model starting from 2 mcg/ml and increasing the dose untile loss of consciousness, Rocuronium 0.6 mg/kg. General Anesthesia mainteneance: Propofol TCI with Schneider site effect model in order to keep an adequate sedation level (BIS between 40-60; entropy between 40-60)

    Procedure: TCI

Interventions

  • ProcedureTCI

    General anesthesia will be induced with a TCI pump

  • ProcedureManual induction

    General anestehsia will be induced and maintained using a pro kilo regimen.

06

What researchers measure

Primary outcomes

  1. Number of patients with Intraprocedural Hypotension

    Descrease of mean blood pressure \> 20% during the procedure from the baseline

    Time frame: Up to three hours

Secondary outcomes

  1. Change from baseline in National Institutes of Health Stroke Scale at 24 hours after acute ischemic stroke

    Change from baseline in National Institutes of Health Stroke Scale (NIHSS) at 24 hours after acute ischemic stroke. The NIHSS is composed of 11 items, each of which scores a specific ability between a 0 and 4. For each item, a score of 0 typically indicates normal function in that specific ability, while a higher score is indicative of some level of impairment.The individual scores from each item are summed in order to calculate a patient's total NIHSS score. The maximum possible score is 42, with the minimum score being a 0

    Time frame: 24 hours after acute ischemic stroke

  2. Change from baseline in National Institutes of Health Stroke Scale at 7 days after acute ischemic stroke

    Change from baseline in National Institutes of Health Stroke Scale (NIHSS) at 7 days after acute ischemic stroke. The NIHSS is composed of 11 items, each of which scores a specific ability between a 0 and 4. For each item, a score of 0 typically indicates normal function in that specific ability, while a higher score is indicative of some level of impairment.The individual scores from each item are summed in order to calculate a patient's total NIHSS score. The maximum possible score is 42, with the minimum score being a 0

    Time frame: 7 days after acute ischemic stroke

  3. Evaluation of Modified Rankin Scale at 3 months after acute ischemic stroke

    Evaluation of Modified Rankin Scale at 3 months after acute ischemic stroke. Modified Rankin Score is a 6 point disability scale with possible scores ranging from 0 to 5. A separate category of 6 is added for patients who expire.

    Time frame: 3 months after acute ischemic stroke

  4. Percentage of patients alive at 3 months after acute ischemic stroke

    Percentage of patients alive at 3 months after acute ischemic stroke

    Time frame: 3 months after acute ischemic stroke

  5. Difference in modified treatment in cerebral infarction (mTICI) score

    Successfull reperfusion in the two groups will be evaluated by modified tratment in cerebral infarction score. modified treatment in cerebral infarction is a five point score (0,1,2a,2b,3) with 0 menaning o reperfusion and 3 complete reperfusion

    Time frame: 24 hours after ischemic stroke

  6. Difference in time from door to groin

    Time will be evaluated from patient admission to the beginning of angiographic procedure

    Time frame: Up to 6 hours

  7. Difference in time from groin to reperfusion

    It will be evaluated the overall time of angiographic procedure

    Time frame: Up to 6 hours

  8. Difference in Intensive Care Unit/Stroke Unit stay

    Overall patient stay in intensive care unit/stroke unit in days

    Time frame: Up to 30 days

07

Study locations

1 site
  • University Hospital of Padova
    Padova, Veneto 35127, Italy
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 28, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT05570682
Lead sponsor
University of Padova
Responsible party
Alessandro De Cassai (Medical Doctor, University of Padova) — Principal investigator
First posted
Oct 6, 2022
Start date
Oct 9, 2022
Primary completion
Oct 9, 2022
Completion
Oct 9, 2022
Last update
Mar 28, 2025

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is withdrawn, as verified in Mar 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion